Status:
UNKNOWN
IVF Outcome in Polycystic Ovary Syndrome Patients
Lead Sponsor:
Assiut University
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
20-40 years
Brief Summary
1. To investigate the circulating concentrations of phoenixin and their associations with BMI, the concentrations of sex hormones including (LH), (FSH), (E2), (P4), (TT) and steroid hormones enzyme in...
Detailed Description
* In vitro fertilization (IVF) is an important tool for those couples with difficulty conceiving or maintaining a pregnancy. In the United States, infants conceived with IVF account for approximately ...
Eligibility Criteria
Inclusion
- • The diagnosis included donors, male factor infertility and PCOS women.
- Age ranging from 20 to 40 years
Exclusion
- • There were no other etiologies for the PCOS cases, such as congenital adrenal hyperplasia, 21-hydroxylase deficiency, androgen-secreting tumors, Cushing's syndrome, thyroid disease, and hyperprolactinemia.
- Patients with endometriosis.
- Patients with history of coronary artery disease, hypertension, liver cirrhosis or hematologic disorders.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 15 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04104958
Start Date
March 1 2020
End Date
February 15 2021
Last Update
January 10 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.